$MDT Headlines Burger King, AbbVie among stocks hit by

New Post Public Reply Private Reply Replies (0) Message Board

Oct 2, 2014 at 1:38 PM

$MDT Headlines

Burger King, AbbVie among stocks hit by new tax inversion rules 2:40 p.m. Sept. 23, 2014 - Ben Eisen
Danaher to buy Nobel Biocare for about $2.1 billion 3:57 a.m. Sept. 15, 2014 - Neil MacLucas
Burger King may buy Canada’s Tim Hortons to cut its taxes 10:30 p.m. Aug. 24, 2014 - Liz Hoffman
Updates, advisories and surprises 6:31 p.m. Aug. 19, 2014 - MarketWatch
Apple sets record close; Loco slides on analyst caution 4:32 p.m. Aug. 19, 2014 - Angela Johnson
Medtronic tops views, reaffirms covidien bid 8:05 a.m. Aug. 19, 2014 - MarketWatch.com
Medtronic profit exceeds expectations 7:29 a.m. Aug. 19, 2014 - Tomi Kilgore
Medtronic affirms fiscal 2015 adj. EPS outlook of $4-$4.10 7:18 a.m. Aug. 19, 2014 - Tomi Kilgore
Medtronic Q1 FactSet sales consensus $4.25 bln 7:18 a.m. Aug. 19, 2014 - Tomi Kilgore
Medtronic Q1 adj. EPS 93 cents vs. FactSet consensus estimate 92 cents 7:17 a.m. Aug. 19, 2014 - Tomi Kilgore
Medtronic Q1 EPS 87 cents, down 6% from year ago 7:17 a.m. Aug. 19, 2014 - Tomi Kilgore
Medtronic Q1 sales $4.27 bln vs. $4.08 bln a year ago 7:16 a.m. Aug. 19, 2014 - Tomi Kilgore
Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Scrap corporate income tax, and make shareholders pay 12:27 p.m. Aug. 6, 2014 - Eric Toder and Alan D. Viard
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
Edwards, Hospira rise as health-care companies see strong earnings 1:08 p.m. July 30, 2014 - blogs.marketwatch.com
Edwards Lifesciences profit soars 4:13 p.m. July 29, 2014 - MarketWatch.com
What the M&A surge says about the stock market 6:01 a.m. July 27, 2014 - William L. Watts

Hottest Healthcare Stocks Now – COV CLVS CNMD EW 4:00 p.m. Oct. 1, 2014 - InvestorPlace.com
FDA publishes guidance on med device cybersecurity 10:05 a.m. Oct. 1, 2014 - Seeking Alpha
Big money flowing to from med firms to docs 8:21 a.m. Oct. 1, 2014 - Seeking Alpha
New Tax Inversion Rules Put Merger Arbitrage ETFs in Focus - ETF News And Commentary 8:00 a.m. Oct. 1, 2014 - Zacks.com
Will This Coverage Initiation Help Medtronic (MDT) Stock Today? 9:23 a.m. Sept. 30, 2014 - TheStreet.com
From Africa to Ukraine, Deal Police Proliferate 10:59 p.m. Sept. 29, 2014 - The Wall Street Journal Interactive Edition
Tax Inversions Help Push Global M&A To 7-Year High 5:33 p.m. Sept. 29, 2014 - Investors Business Daily
TriVascular Technologies: A Strong Short Candidate 12:02 p.m. Sept. 29, 2014 - Seeking Alpha
Why Medtronic (MDT) Stock Is Down Today 8:26 a.m. Sept. 29, 2014 - TheStreet.com
3 Medical Devices Stocks to Buy Now 4:30 a.m. Sept. 29, 2014 - InvestorPlace.com
5 Fairly Valued Companies Worthy Of Further Research This Week 10:11 a.m. Sept. 28, 2014 - Seeking Alpha
10 Healthcare Dogs: 12% To 35% September Upsides, 1 Runt Hits 75% 6:38 a.m. Sept. 27, 2014 - Seeking Alpha
Citizen Hackers Tinker With Medical Devices 6:25 p.m. Sept. 26, 2014 - The Wall Street Journal Interactive Edition
Medical Technology Company Offers Investment Opportunity 3:00 p.m. Sept. 25, 2014 - GuruFocus.com
Top Analyst Upgrades and Downgrades: Alcoa, BHP Billiton, 58.com, KB Home, Yahoo and More 7:41 a.m. Sept. 25, 2014 - 247WallSt.com
Morgan Stanley Sees Ways For Medtronic, Inc. To Create Value 7:15 a.m. Sept. 25, 2014 - benzinga.com
Medtronic Quarterly Stock Valuation 2:34 p.m. Sept. 24, 2014 - Seeking Alpha
New Tax Rules to Slow, Not Halt, Inversion Deals 12:57 p.m. Sept. 24, 2014 - The Wall Street Journal Interactive Edition
Stock Market News for September 24, 2014 - Market News 10:10 a.m. Sept. 24, 2014 - Zacks.com
Hedge Funds Jostled in Inversion Deals 12:01 a.m. Sept. 24, 2014 - The Wall Street Journal Interactive Edition

WeissLaw LLP Announces Class Action Lawsuit Against Covidien plc 6:11 p.m. Oct. 1, 2014 - PR Newswire - PRF
Legal Settlement, Data Presentation, Welfare Initiatives, Acquisition Talks, and Study Results - Research Reports on Shire, Merck, Medtronic, Salix and Johnson & Johnson 9:10 a.m. Oct. 1, 2014 - PR Newswire - PRF
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Covidien plc of Class Action Against Its Board of Directors in Connection With the Sale of the Company to Medtronic, Inc. -- COV 4:19 p.m. Sept. 29, 2014 - GlobeNewswire
Medtronic Extends Title Sponsorship of Twin Cities Marathon Through 2020 9:01 a.m. Sept. 29, 2014 - Thomson Reuters ONE
Health Care Equipment Equities under the Scanner - Medtronic, Abbott Laboratories, Stryker, Zeltiq Aesthetics, and EnteroMedics 8:40 a.m. Sept. 26, 2014 - PR Newswire - PRF
Medtronic Announces $6 Million Philanthropic Effort to Prevent and Control Rheumatic Heart Disease 11:00 a.m. Sept. 25, 2014 - Thomson Reuters ONE
Agility Health Provides Corporate Update: Successful Year Yields Positive Outlook for Continued Growth 5:30 a.m. Sept. 24, 2014 - Marketwire
Wearable Technology Market Report 2014-2019 4:15 p.m. Sept. 23, 2014 - PR Newswire - PRF
Inaugural Gala to Launch New Scholarship, Financial Aid Program as YFU Returns its Headquarters to Nation's Capital 3:48 p.m. Sept. 23, 2014 - GlobeNewswire
Regulatory Approval, Presentation of Data, Appointment, Clinical Study Results, and Increase in Quarterly Dividend - Research Reports on Johnson & Johnson, Merck, Medtronic, Amgen and Covidien 9:05 a.m. Sept. 23, 2014 - PR Newswire - PRF
Medtronic Announces CE Mark and European Launch of TYRX(TM) Absorbable Antibacterial Envelope 9:30 a.m. Sept. 22, 2014 - Thomson Reuters ONE
Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave, Cryotherapy) - Global Industry Analysis, Size, Share, 4:41 p.m. Sept. 17, 2014 - PR Newswire - PRF
Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry 4:38 p.m. Sept. 17, 2014 - PR Newswire - PRF
Medtronic Elects Elizabeth Nabel to the Board of Directors 4:30 p.m. Sept. 17, 2014 - Thomson Reuters ONE
Medtronic Launches New Balloon Kyphoplasty Products for Treating Spinal Fractures 9:00 a.m. Sept. 17, 2014 - Thomson Reuters ONE
Ortho Kinematics Enters Agreement with Medtronic for Promotion of VMA 8:47 a.m. Sept. 16, 2014 - BusinessWire - BZX
Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease 8:00 a.m. Sept. 16, 2014 - Thomson Reuters ONE
LifeScience Alley®30th Anniversary Conference to Feature Global Healthcare Leaders 4:05 p.m. Sept. 15, 2014 - BusinessWire - BZX
New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma 9:15 a.m. Sept. 15, 2014 - PR Newswire - PRF
Medtronic Launches SEEQ(TM) Wearable Cardiac Monitoring System in United States 8:00 a.m. Sept. 15, 2014 - Thomson Reuters ONE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lassa's Wintus 3: Boosting Winter Tyre Game for 2026

Rolling Through Winter: Lassa's Next Step Ever felt like you were skating on thin ice with your vehicle in winter? That's why Lassa has cranked out the Wintus 3—a tyre making waves in the chilly game. Now, we're not talking about your run-of-the-mill rubber. This is a strategic play by a Turkish powerhouse, Brisa, aimed squarely at those who rely on light commercial...

Dimora Medical Boosts Advanced Wound Care at HS Conference

Empowering the HS Community with Innovations Look, if you’ve walked a mile in someone else's shoes—particularly ones dealing with hidradenitis suppurativa (HS)—you’d know what a relentless grind managing those exuding wounds can be. Dimora Medical, known for navigating the tricky territory of wound care, threw its hat into the ring at the HS Connect Empower...

Solenis Appoints Brendy Lange to Lead Americas Growth

New Leadership at Solenis Change is brewing at Solenis, and it's set to ripple across the water treatment industry like a stone in a pond. Brendy Lange's appointment as Chief Business Officer, Americas, promises to shake things up in a firm as committed to innovation as Solenis. This seasoned executive, scooped from the ranks of Dow Chemical, steps in with a mandate to...

Ractigen's LiCO™ Platform Hits Extrahepatic Milestones

Breaking New Ground in RNA Therapeutics Hey, in the world of biotech, landing a meaningful delivery system is like striking gold, and it seems Ractigen Therapeutics just found a shiny nugget. Their latest study on the LiCO™ platform, living and breathing in the pages of Molecular Therapy - Nucleic Acids, maps out a path to some serious therapeutic territory. These guys...

Galien Recognizes Kerry for Transformative Global Health Work

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...

Cboe Clear's US Move: A New Chapter with SEC Nod

Clearing the Path for New Beginnings The ink's barely dry on Cboe Clear U.S.'s recent SEC registration, and it's already setting tongues wagging among market old-timers. This move to clear binary securities options alongside futures isn't just a step up; it's a signal flare for ambitious innovation. The Nuts and Bolts: SEC Registration So, what's the big to-do? Cboe Clear...

Rakuten Medical's Long-Term Data Shows Promise

This Isn't Just Another Cancer Update Alright, folks, let's unwrap what's happening today with Rakuten Medical. They've thrown some serious numbers into the ring at the ESMO Congress 2026 in Madrid. We're talking long-term follow-up results of their ASP-1929 photoimmunotherapy combined with pembrolizumab in tackling recurrent and metastatic head and neck squamous cell...

SAFE Structure Designs Backs Prosthetic Nonprofit 50 Legs

A Partnership Rooted in Service and Faith Let's face it, support from major companies for nonprofits isn't exactly commonplace. But every so often, you run into a partnership that catches your eye, and this one's got a little extra heart. SAFE Structure Designs, known for its defense engineering prowess in Las Vegas, is throwing its weight behind Clearwater's 50 Legs....

S&P Global's New Dashboard: Unpacking Data Insights

An Interactive Take on Digital Infrastructure The geniuses over at S&P Global Ratings have just unleashed a shiny new tool for number crunchers and market hawks who can't get enough data center action—an interactive dashboard. Maybe not everyone’s cup of tea, but hey, in the dog-eat-dog world of digital infrastructure, any edge counts. What's in the Data Center Soup?...

TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...